1887

Abstract

is the causative agent of both superficial and deep-seated infections of increasing morbidity and mortality. Urinary tract infections (UTIs) due to , frequently associated with indwelling medical devices, have been reported over the years. However, few studies have specifically focused on the genotypic diversity of isolates from urine specimens from intensive care units (ICUs), let alone potential virulence factors and antifungal susceptibility testing. In the present study, 23 isolates were collected from UTI patients in ICUs between January 2008 and January 2012. Three genotypes (I, III, IV) were determined based on the combination of internal transcribed spacer and intergenic spacer locus PCR. Protease, phospholipase and haemolysin production was assessed by halo formation on corresponding agar plates. Only haemolytic activity was observed to varying degrees. Neither protease nor phospholipase was detectable. Biofilm formation on polystyrene surfaces was detected through a formazan salt reduction assay. All clinical isolates had the ability to form biofilm. In contrast to the susceptibility of planktonic cells to clinically used amphotericin B, 5-flucytosine, fluconazole, itraconazole and voriconazole, a remarkable rise in the MICs of these for biofilm cells was observed. Our results suggested that genotype IV was the most prevalent genotype among isolates from ICUs in China. Haemolysin and biofilm might contribute to the pathogenicity and recurrence of -related UTIs. Although triazoles, especially voriconazole, were effective against planktonic cells, they failed to treat preformed biofilms.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.049817-0
2012-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/12/1750.html?itemId=/content/journal/jmm/10.1099/jmm.0.049817-0&mimeType=html&fmt=ahah

References

  1. Ahmad S., Khan Z., Mokaddas E., Khan Z. U. 2004; Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 53:633–637 [View Article][PubMed]
    [Google Scholar]
  2. Bayramoglu G., Sonmez M., Tosun I., Aydin K., Aydin F. 2008; Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 36:68–70 [View Article][PubMed]
    [Google Scholar]
  3. Chagas-Neto T. C., Chaves G. M., Melo A. S., Colombo A. L. 2009; Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 47:1074–1081 [View Article][PubMed]
    [Google Scholar]
  4. Colombo A. L., Padovan A. C., Chaves G. M. 2011; Current knowledge of Trichosporon spp. and trichosporonosis. Clin Microbiol Rev 24:682–700 [View Article][PubMed]
    [Google Scholar]
  5. Dagdeviren M., Cerikcioglu N., Karavus M. 2005; Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses 48:321–326 [View Article][PubMed]
    [Google Scholar]
  6. Di Bonaventura G., Pompilio A., Picciani C., Iezzi M., D’Antonio D., Piccolomini R. 2006; Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 50:3269–3276 [View Article][PubMed]
    [Google Scholar]
  7. Fera M. T., La Camera E., De Sarro A. 2009; New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther 7:981–998 [View Article][PubMed]
    [Google Scholar]
  8. Frank D. N., Wilson S. S., St Amand A. L., Pace N. R. 2009; Culture-independent microbiological analysis of Foley urinary catheter biofilms. PLoS ONE 4:e7811 [View Article][PubMed]
    [Google Scholar]
  9. Furlaneto-Maia L., Specian A. F., Bizerra F. C., de Oliveira M. T., Furlaneto M. C. 2008; In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia 166:209–217 [View Article][PubMed]
    [Google Scholar]
  10. Girmenia C., Pagano L., Martino B., D’Antonio D., Fanci R., Specchia G., Melillo L., Buelli M., Pizzarelli G. other authors 2005; Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 43:1818–1828 [View Article][PubMed]
    [Google Scholar]
  11. Guo L. N., Xiao M., Kong F., Chen S. C., Wang H., Sorrell T. C., Jiang W., Dou H. T., Li R. Y., Xu Y. C. 2011; Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol 49:3805–3811 [View Article][PubMed]
    [Google Scholar]
  12. Hawser S. P., Norris H., Jessup C. J., Ghannoum M. A. 1998; Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36:1450–1452[PubMed]
    [Google Scholar]
  13. Kalkanci A., Sugita T., Arikan S., Yucesoy M., Ener B., Otag F., Kiraz N., Kustimur S., Sancak B. other authors 2010; Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol 48:141–146 [View Article][PubMed]
    [Google Scholar]
  14. Kauffman C. A., Vazquez J. A., Sobel J. D., Gallis H. A., McKinsey D. S., Karchmer A. W., Sugar A. M., Sharkey P. K., Wise G. J. other authors 2000; Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30:14–18 [View Article][PubMed]
    [Google Scholar]
  15. Krzossok S., Birck R., Henke S., Hof H., van der Woude F. J., Braun C. 2004; Trichosporon asahii infection of a dialysis PTFE arteriovenous graft. Clin Nephrol 62:66–68[PubMed] [CrossRef]
    [Google Scholar]
  16. Kumar S., Bandyopadhyay M., Mondal S., Pal N. 2011; A rare case of nosocomial urinary tract infection due to Trichosporon asahii . J Glob Infect Dis 3:309–310 [View Article][PubMed]
    [Google Scholar]
  17. Lundstrom T., Sobel J. 2001; Nosocomial candiduria: a review. Clin Infect Dis 32:1602–1607 [View Article][PubMed]
    [Google Scholar]
  18. Luo G., Samaranayake L. P., Yau J. Y. 2001; Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 39:2971–2974 [View Article][PubMed]
    [Google Scholar]
  19. Makimura K., Murayama S. Y., Yamaguchi H. 1994; Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 40:358–364 [View Article][PubMed]
    [Google Scholar]
  20. Martinez-Lacasa J., Maña J., Niubó R., Rufi G., Saez A., Fernández-Nogués F. 1991; Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii . Eur J Clin Microbiol Infect Dis 10:756–758 [View Article][PubMed]
    [Google Scholar]
  21. Marty F. M., Barouch D. H., Coakley E. P., Baden L. R. 2003; Disseminated trichosporonosis caused by Trichosporon loubieri . J Clin Microbiol 41:5317–5320 [View Article][PubMed]
    [Google Scholar]
  22. Mekha N., Sugita T., Ikeda R., Nishikawa A., Autthateinchai R., Poonwan N., Sawanpanyalert P. 2010; Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 169:67–70 [View Article][PubMed]
    [Google Scholar]
  23. Mirza S. H. 1993; Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient. J Infect 27:67–70 [View Article][PubMed]
    [Google Scholar]
  24. Mooty M. Y., Kanj S. S., Obeid M. Y., Hassan G. Y., Araj G. F. 2001; A case of Trichosporon beigelii endocarditis. Eur J Clin Microbiol Infect Dis 20:139–142[PubMed]
    [Google Scholar]
  25. Moretti-Branchini M. L., Fukushima K., Schreiber A. Z., Nishimura K., Papaiordanou P. M., Trabasso P., Tanaka R., Miyaji M. 2001; Trichosporon species infection in bone marrow transplanted patients. Diagn Microbiol Infect Dis 39:161–164 [View Article][PubMed]
    [Google Scholar]
  26. CLSI 2009 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Informational Supplement. M27-A3 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  27. Negri M., Martins M., Henriques M., Svidzinski T. I., Azeredo J., Oliveira R. 2010; Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia 169:175–182 [View Article][PubMed]
    [Google Scholar]
  28. Padhye A. A., Hall L., Roberts G. D. 2002; Deep-seated trichosporonosis in an immunocompetent patient: a case report of uterine trichosporonosis – correction. Clin Infect Dis 35:108–109, author reply 109 [View Article][PubMed]
    [Google Scholar]
  29. Pini G., Faggi E., Donato R., Fanci R. 2005; Isolation of Trichosporon in a hematology ward. Mycoses 48:45–49 [View Article][PubMed]
    [Google Scholar]
  30. Price M. F., Wilkinson I. D., Gentry L. O. 1982; Plate method for detection of phospholipase activity in Candida albicans . Sabouraudia 20:7–14 [View Article][PubMed]
    [Google Scholar]
  31. Rastogi V. L., Nirwan P. S. 2007; Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol 25:59–61 [View Article][PubMed]
    [Google Scholar]
  32. Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P. 2000; Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21:510–515 [View Article][PubMed]
    [Google Scholar]
  33. Rodriguez-Tudela J. L., Diaz-Guerra T. M., Mellado E., Cano V., Tapia C., Perkins A., Gomez-Lopez A., Rodero L., Cuenca-Estrella M. 2005; Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 49:4026–4034 [View Article][PubMed]
    [Google Scholar]
  34. Rodriguez-Tudela J. L., Gomez-Lopez A., Alastruey-Izquierdo A., Mellado E., Bernal-Martinez L., Cuenca-Estrella M. 2007; Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 58:435–440 [View Article][PubMed]
    [Google Scholar]
  35. Sabharwal E. R. 2010; Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian J Pathol Microbiol 53:387–388 [View Article][PubMed]
    [Google Scholar]
  36. Shin J. H., Kee S. J., Shin M. G., Kim S. H., Shin D. H., Lee S. K., Suh S. P., Ryang D. W. 2002; Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40:1244–1248 [View Article][PubMed]
    [Google Scholar]
  37. Sood S., Pathak D., Sharma R., Rishi S. 2006; Urinary tract infection by Trichosporon asahii . Indian J Med Microbiol 24:294–296 [View Article][PubMed]
    [Google Scholar]
  38. Sugita T., Ichikawa T., Matsukura M., Sueda M., Takashima M., Ikeda R., Nishikawa A., Shinoda T. 2001; Genetic diversity and biochemical characteristics of Trichosporon asahii isolated from clinical specimens, houses of patients with summer-type-hypersensitivity pneumonitis, and environmental materials. J Clin Microbiol 39:2405–2411 [View Article][PubMed]
    [Google Scholar]
  39. Sugita T., Nakajima M., Ikeda R., Matsushima T., Shinoda T. 2002; Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 40:1826–1830 [View Article][PubMed]
    [Google Scholar]
  40. Walsh T. J., Groll A., Hiemenz J., Fleming R., Roilides E., Anaissie E. 2004; Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10:Suppl. 148–66 [View Article][PubMed]
    [Google Scholar]
  41. Wolf D. G., Falk R., Hacham M., Theelen B., Boekhout T., Scorzetti G., Shapiro M., Block C., Salkin I. F., Polacheck I. 2001; Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 39:4420–4425 [View Article][PubMed]
    [Google Scholar]
  42. Xia Z., Yang R., Wang W., Cong L. 2012; Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Mycopathologia 173:127–133 [View Article][PubMed]
    [Google Scholar]
  43. Yun S. J., Lee J. B., Shin M. G., Kim S. J., Won Y. H., Lee S. C. 2006; Cutaneous abscess by Trichosporon asahii developing on a steroid injection site in a healthy adult. Clin Exp Dermatol 31:545–547 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.049817-0
Loading
/content/journal/jmm/10.1099/jmm.0.049817-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error